Advice on the investigation and management of patients who may be infected with a new SARS-CoV-2 Variant of Concern. Category: UncategorisedBy 16 February 2021Leave a commentPost navigationPreviousPrevious post:Guidance: COVID-19: guidance on shielding and protecting people defined on medical grounds as extremely vulnerableNextNext post:Research and analysis: Notifiable diseases: last 52 weeks